Literature DB >> 19118316

Antidepressants on trial: how valid is the evidence?

Gordon Parker.   

Abstract

A recent meta-analysis concluded that newer antidepressant drugs are equivalent to or no better than placebos, a conclusion at some variance with their commonly judged clinical effectiveness. The 'disconnect' between randomised controlled trials and clinical practice would benefit from dissection of contributing factors, and redressing limitations to current trial procedures.

Mesh:

Substances:

Year:  2009        PMID: 19118316     DOI: 10.1192/bjp.bp.108.054767

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression.

Authors:  Emanuel Severus; Florian Seemüller; Michael Berger; Sandra Dittmann; Michael Obermeier; Andrea Pfennig; Michael Riedel; Sophia Frangou; Hans-Jürgen Möller; Michael Bauer
Journal:  BMC Med       Date:  2012-07-02       Impact factor: 8.775

2.  Chronic medical conditions mediate the association between depression and cardiovascular disease mortality.

Authors:  Evan Atlantis; Zumin Shi; Brenda J W H Penninx; Gary A Wittert; Anne Taylor; Osvaldo P Almeida
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-08       Impact factor: 4.328

3.  Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress.

Authors:  Shanshan Zhang; Juntao Hu; Guixue Liu; Haoran Wu; Meihui Li; Chenye Shi; Qiong Liu; Wensheng Li
Journal:  Transl Psychiatry       Date:  2022-06-10       Impact factor: 7.989

4.  Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.

Authors:  David A Mrazek; Joanna M Biernacka; Donald E McAlpine; Joachim Benitez; Victor M Karpyak; Mark D Williams; Daniel K Hall-Flavin; Pamela J Netzel; Victoria Passov; Barbara M Rohland; Gen Shinozaki; Astrid A Hoberg; Karen A Snyder; Maureen S Drews; Michelle K Skime; Jessica A Sagen; Daniel J Schaid; Richard Weinshilboum; David J Katzelnick
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

5.  Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain.

Authors:  Gerard Honig; Minke E Jongsma; Marieke C G van der Hart; Laurence H Tecott
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

6.  Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study.

Authors:  Ricardo Gusmão; Sónia Quintão; David McDaid; Ella Arensman; Chantal Van Audenhove; Claire Coffey; Airi Värnik; Peeter Värnik; James Coyne; Ulrich Hegerl
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

7.  Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.

Authors:  F Hieronymus; J F Emilsson; S Nilsson; E Eriksson
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

8.  Practitioner perspectives on strategies to promote longer-term benefits of acupuncture or counselling for depression: a qualitative study.

Authors:  Hugh MacPherson; Liz Newbronner; Ruth Chamberlain; Stewart J Richmond; Harriet Lansdown; Sara Perren; Ann Hopton; Karen Spilsbury
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.